This book discusses how biological models are used in the development of radiopharmaceuticals—compounds labelled with radionuclides that are used for imaging or treating diseases. It covers how to design candidate radiopharmaceuticals, choose appropriate biological models (animal species, transgenic models, in vitro vs in vivo), and how tomographic physiological chemistry (PET, SPET etc.) pla…